Evidence map›Paper›PMID 26878240›Full record

ArticleNature structural & molecular biology2016

7SK-BAF axis controls pervasive transcription at enhancers.

Ryan A Flynn, Brian T Do, Adam J Rubin, Eliezer Calo, Byron Lee, Hannes Kuchelmeister, Michael Rale, Ci Chu, Eric T Kool, Joanna Wysocka and 2 more

Abstract read
In one paragraph

Article in Nature structural & molecular biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 119 citations in OpenAlex.

  1. Article
  2. An RNA mark for pluripotency.Nature chemical biology · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Ryan A FlynnCenter for Personal Dynamic Regulomes, Stanford University School of Medicine, Stanford, California, USA.ORCID http://orcid.org/0000-0001-5013-0442
Brian T DoCenter for Personal Dynamic Regulomes, Stanford University School of Medicine, Stanford, California, USA.
Adam J RubinProgram in Epithelial Biology, Stanford University School of Medicine, Stanford, California, USA.
Eliezer CaloDepartment of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, California, USA.
Byron LeeCenter for Personal Dynamic Regulomes, Stanford University School of Medicine, Stanford, California, USA.
Hannes KuchelmeisterDepartment of Chemistry, Stanford University, Stanford, California, USA.
Michael RaleThe Genome Institute, Washington University in St. Louis, St. Louis, Missouri, USA.
Ci ChuCenter for Personal Dynamic Regulomes, Stanford University School of Medicine, Stanford, California, USA.
Eric T KoolDepartment of Chemistry, Stanford University, Stanford, California, USA.
Joanna WysockaDepartment of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, California, USA.
Paul A KhavariProgram in Epithelial Biology, Stanford University School of Medicine, Stanford, California, USA.
Howard Y ChangCenter for Personal Dynamic Regulomes, Stanford University School of Medicine, Stanford, California, USA.
Stanford University · USWashington University in St. Louis · US

Funding

Translational Oncology Research Program (Project-005)P30CA124435 · NCI · STANFORD UNIVERSITY · PI Melinda L. Telli · 2007 to 2026
$71.4M
Special EquipmentP50HG007735 · NHGRI · STANFORD UNIVERSITY · PI CHANG, HOWARD Y · 2014 to 2018
$15.2M
Structural Motifs in RNAR01HG004361 · NHGRI · STANFORD UNIVERSITY · PI CHANG, HOWARD Y · 2007 to 2018
$4.7M
Templated Chemistry for RNA AnalysisR01GM068122 · NIGMS · STANFORD UNIVERSITY · PI KOOL, ERIC T. · 2003 to 2016
$3.5M
Highly Reactive Hydrazone Chemistry: Orthogonal Modification in Cellular ContextsR01GM110050 · NIGMS · STANFORD UNIVERSITY · PI KOOL, ERIC T. · 2015 to 2018
$1.2M
Mechanisms of enhancer activation in early developmentR01GM112720 · NIGMS · STANFORD UNIVERSITY · PI WYSOCKA, JOANNA · 2015 to 2018
$1.2M
CONTROL OF TRANSCRIPTION BY THE 7SK RNA IN BREAST CANCERF30CA189514 · NCI · STANFORD UNIVERSITY · PI FLYNN, RYAN ALEXANDER · 2014 to 2015
$96k
Howard Hughes Medical InstituteNCI NIH HHS 1F30CA189514-01NCI NIH HHS F30 CA189514NCI NIH HHS P30 CA124435NHGRI NIH HHS P50 HG007735NHGRI NIH HHS P50-HG007735NHGRI NIH HHS R01 HG004361NHGRI NIH HHS R01-HG004361NIGMS NIH HHS GM068122NIGMS NIH HHS GM110050NIGMS NIH HHS R01 GM068122NIGMS NIH HHS R01 GM110050NIGMS NIH HHS R01 GM112720
6 · The paper itself

Abstract

RNA functions at enhancers remain mysterious. Here we show that the 7SK small nuclear RNA (snRNA) inhibits enhancer transcription by modulating nucleosome position. 7SK occupies enhancers and super enhancers genome wide in mouse and human cells, and it is required to limit enhancer-RNA initiation and synthesis in a manner distinct from promoter pausing. Clustered elements at super enhancers uniquely require 7SK to prevent convergent transcription and DNA-damage signaling. 7SK physically interacts with the BAF chromatin-remodeling complex, recruits BAF to enhancers and inhibits enhancer transcription by modulating chromatin structure. In turn, 7SK occupancy at enhancers coincides with that of Brd4 and is exquisitely sensitive to the bromodomain inhibitor JQ1. Thus, 7SK uses distinct mechanisms to counteract the diverse consequences of pervasive transcription that distinguish super enhancers, enhancers and promoters.

Indexed as

Enhancer Elements, GeneticGene Expression RegulationTranscription, GeneticAnimalsCell LineDNA-Binding ProteinsHumansMiceNucleosomesRNA, Small NuclearDNA-Binding ProteinsNucleosomesRNA, Small Nuclear

Identifiers

PMID26878240
PMCPMC4982704
OpenAlexW2276045700

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.